Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION AND NATURE OF BUSINESS (Details Narrative)

v3.23.2
BASIS OF PRESENTATION AND NATURE OF BUSINESS (Details Narrative)
6 Months Ended
Jun. 30, 2023
USD ($)
Integer
U.S. Patents owned by the company 98
Expired patents 53
Foreign patents owned by the company 14
ILiAD Biotechnologies, LLC [Member]  
Aggregate investment amount | $ $ 7,000,000